[Analysis of the risk factors for vascular pain induced by the administration of pirarubicin].
Dept. of Pharmacy, National Hospital Organization, Kyushu Medical Center.
Takashi
T
Goto
Kazuki
K
Tanimoto
Kazuhiro
K
Furumi
Masahiro
M
Nakano
Makoto
M
Ishibashi
Seiichi
S
Okamura
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D004317:Doxorubicin / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007262:Infusions, Intravenous; D008228:Lymphoma, Non-Hodgkin / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D010146:Pain / Q000139:chemically induced*; D012307:Risk Factors; D014680:Veins / Q000187:drug effects
D000970:Antineoplastic Agents; D004317:Doxorubicin; C027260:pirarubicin